FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karl Swedberg

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Karl Swedberg; Michal Tendera; Dirk J van Veldhuisen; James B Young; Inder S Anand; Sunfa Cheng; Akshay S Desai; Rafael Diaz; Aldo P Maggioni; John J V McMurray; Christopher O'Connor; Marc A Pfeffer; Scott D Solomon; Yan Sun
Treatment of anemia with darbepoetin alfa in systolic heart failure.
John J V McMurray; Christopher O'Connor; Marc A Pfeffer; Debra Scarlata; Scott D Solomon; Karl Swedberg; Michal Tendera; Dirk J van Veldhuisen; James B Young; Moetaz Albizem; Inder S Anand; Sunfa Cheng; Rafael Diaz; Aldo P Maggioni
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).
Lars-Eric Olsson; Karl Swedberg; Eva Jakobsson Ung; Inger Ekman
Efficacy of person-centred care as an intervention in controlled trials - a systematic review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karl Swedberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Karl Swedberg; Michal Tendera; Dirk J van Veldhuisen; James B Young; Inder S Anand; Sunfa Cheng; Akshay S Desai; Rafael Diaz; Aldo P Maggioni; John J V McMurray; Christopher O'Connor; Marc A Pfeffer; Scott D Solomon; Yan Sun
Treatment of anemia with darbepoetin alfa in systolic heart failure.
The New England journal of medicine 2013;368(13):1210-9.
2013: John J V McMurray; Christopher O'Connor; Marc A Pfeffer; Debra Scarlata; Scott D Solomon; Karl Swedberg; Michal Tendera; Dirk J van Veldhuisen; James B Young; Moetaz Albizem; Inder S Anand; Sunfa Cheng; Rafael Diaz; Aldo P Maggioni
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).
European journal of heart failure 2013;15(3):334-41.
2013: Lars-Eric Olsson; Karl Swedberg; Eva Jakobsson Ung; Inger Ekman
Efficacy of person-centred care as an intervention in controlled trials - a systematic review.
Journal of clinical nursing 2013;22(3-4):456-65.
2013: Satyam Sarma; Haris Subacius; Karl Swedberg; Faiez Zannad; Robert O Bonow; Angela J Fought; Mihai Gheorghiade; Mark Huffman; Marvin Konstam; Mary J Kwasny; Aldo P Maggioni; Robert J Mentz; Savina Nodari
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.
European journal of heart failure 2013;15(2):194-202.
2013: Robert J Mentz; Christopher M O'Connor; Karl Swedberg; James E Udelson; Muthiah Vaduganathan; Faiez Zannad; Bradley D Allen; Andrew P Ambrosy; Robert O Bonow; Angela J Fought; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni; Mihai Gheorghiade
Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.
European journal of heart failure 2013;15(1):61-8.
2013: Michael Böhm; Jeffrey Borer; Ian Ford; Jose R Gonzalez-Juanatey; Michel Komajda; Jose Lopez-Sendon; Jan-Christian Reil; Karl Swedberg; Luigi Tavazzi
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
Clinical research in cardiology : official journal of the German Cardiac Society 2013;102(1):11-22.
2012: Ami N Shah; Karl Swedberg; Faiez Zannad; Angela J Fought; Mihai Gheorghiade; Mary J Kwasny; Aldo P Maggioni; Robert J Mentz; Marvin A Konstam
Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial).
The American journal of cardiology 2012;110(12):1803-8.
2012: Robert J Mentz; Christopher M O'Connor; Peter S Pang; Karl Swedberg; Muthiah Vaduganathan; Faiez Zannad; Andrew P Ambrosy; Matthew J Chung; Mihai Gheorghiade; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni
Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
American heart journal 2012;164(6):884-92.e2.
2012: Stephen J Greene; Matthew E Harinstein; Marvin A Konstam; Aldo P Maggioni; Haris Subačius; Karl Swedberg; Muthiah Vaduganathan; Faiez Zannad; Javed Butler; Mihai Gheorghiade
Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
The American journal of cardiology 2012;110(11):1657-62.
2012: David Preiss; Naveed Sattar; Harry Shi; Karl Swedberg; Dirk J van Veldhuisen; John Vincent; Faiez Zannad; Henry Krum; Bertram Pitt; Stuart J Pocock; John J V McMurray
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
European journal of heart failure 2012;14(8):909-15.
2012: Robert J Mentz; Christopher M O'Connor; Philip H Schmidt; Karl Swedberg; Faiez Zannad; Andrew P Ambrosy; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni; Mihai Gheorghiade
The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial.
Journal of cardiac failure 2012;18(7):515-23.
2012: Yangzhen Shao; Karl Swedberg; Alexander R Lyon; Bjorn Redfors; Annika Rosengren; Elmir Omerovic
Trends in publications on stress-induced cardiomyopathy.
International journal of cardiology 2012;157(3):435-6.
2012: Karl Swedberg; Luigi Tavazzi; Michael Böhm; Jeffrey Borer; Ian Ford; Michel Komajda; Michele Robertson
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Journal of the American College of Cardiology 2012;59(22):1938-45.
2012: Karl Swedberg; Dirk J van Veldhuisen; John Vincent; Faiez Zannad; Henry Krum; John J V McMurray; Bertram Pitt; Harry Shi
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.
Journal of the American College of Cardiology 2012;59(18):1598-603.
2012: Karl Swedberg; Michel Komajda
The beat goes on: on the importance of heart rate in chronic heart failure.
European heart journal 2012;33(9):1044-5.
2012: Mihai Gheorghiade; Liliana Grinfeld; Marvin Konstam; Gloria Lan; Aldo Maggioni; Peter S Pang; Philip Schmidt; Karl Swedberg; Brian Traver; James Udelson; Andrew P Ambrosy; John Burnett; Thomas Cook; Gerasimos Filippatos; Faiez Zannad
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.
Heart failure reviews 2012;17(3):485-509.
2012: Inger Ekman; Lars-Eric Olsson; Maria Schaufelberger; Charles Taft; Axel Wolf; Kerstin Dudas; Karl Swedberg
Effects of person-centred care in patients with chronic heart failure: the PCC-HF study.
European heart journal 2012;33(9):1112-9.
2012: Axel Wolf; Lars-Eric Olsson; Karl Swedberg; Charles Taft; Inger Ekman
Impacts of patient characteristics on hospital care experience in 34,000 Swedish patients.
BMC nursing 2012;11():8.
2012: Masoud Shafazand; Karl Swedberg; Inger Ekman; Harshidaben Patel; Maria Schaufelberger
Patients with worsening chronic heart failure who present to a hospital emergency department require hospital care.
BMC research notes 2012;5():132.
2011: Inger Ekman; Inga-Lill Johansson; Karin Kjellgren; Eva Lidén; Anders Lindseth; Astrid Norberg; Lars-Eric Olsson; Hans Rosén; Martin Rydmark; Eva Brink; Jane Carlsson; Synneve Dahlin Ivanoff; Karl Swedberg; Charles Taft; Joakim Ohlén; Katharina Sunnerhagen
Person-centered care--ready for prime time.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2011;10(4):248-51.
2011: Inger Ekman; Ian Ford; Michel Komajda; Michael Böhm; Jeffrey S Borer; Olivier Chassany; Luigi Tavazzi; Karl Swedberg
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.
European heart journal 2011;32(19):2395-404.
2011: Inger Ekman; Kristin Falk; Barbro Kjellström; Jonna Norman; Karl Swedberg
Impact of device-guided slow breathing on symptoms of chronic heart failure: a randomized, controlled feasibility study.
European journal of heart failure 2011;13(9):1000-5.
2011: Christopher M O'Connor; Karl Swedberg; Michael Caron; Peter E Carson; Gordon W Davis; Mona Fiuzat; Wendy Gattis-Stough; Bruce Koch; Michael R Bristow
Influence of global region on outcomes in heart failure β-blocker trials.
Journal of the American College of Cardiology 2011;58(9):915-22.
2011: Inger Ekman; Bradi Granger; Hans Stenlund; Karl Swedberg; Kurt Boman
Measuring shortness of breath in heart failure (SOB-HF): development and validation of a new dyspnoea assessment tool.
European journal of heart failure 2011;13(8):838-45.
2011: Peter S Pang; Mihai Gheorghiade; Jamil Dihu; Karl Swedberg; Sadiya Khan; Aldo P Maggioni; Liliana Grinfeld; Faiez Zannad; John C Burnett; John Ouyang; James E Udelson; Marvin A Konstam
Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials.
American heart journal 2011;161(6):1067-72.
2011: Masoud Shafazand; Annika Rosengren; Georg Lappas; Karl Swedberg; Maria Schaufelberger
Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993-2004: a study of 175,216 patients with a first acute myocardial infarction in Sweden.
European journal of heart failure 2011;13(2):135-41.
2011: Jens jakob Thune; James E Signorovitch; Lars Kober; John J V McMurray; Karl Swedberg; Jean Rouleau; Aldo Maggioni; Eric J Velazquez; Robert Califf; Marc A Pfeffer; Scott D Solomon
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
European journal of heart failure 2011;13(2):148-53.
2011: Jan-Christian Reil; Florian Custodis; Karl Swedberg; Michel Komajda; Jeffrey S Borer; Ian Ford; Luigi Tavazzi; Ulrich Laufs; Michael Böhm
Heart rate reduction in cardiovascular disease and therapy.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(1):11-9.
2010: Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Lancet 2010;376(9744):875-85.
2010: Michael Böhm; Karl Swedberg; Michel Komajda; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Lancet 2010;376(9744):886-94.
2010: Henriette Philipson; Inger Ekman; Karl Swedberg; Maria Schaufelberger
A pilot study of salt and water restriction in patients with chronic heart failure.
Scandinavian cardiovascular journal : SCJ 2010;44(4):209-14.
2010: Benjamin M Scirica; David A Morrow; Christoph Bode; Witold Ruzyllo; Mikhail Ruda; Anthonius J M Oude Ophuis; Jose Lopez-Sendon; Karl Swedberg; Michal Ogorek; Nader Rifai; Valentina Lukashevich; Mojdeh Maboudian; Christopher P Cannon; Carolyn H McCabe; Eugene Braunwald
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.
European heart journal 2010;31(16):1993-2005.
2010: Norman C Wang; Jonathan P Piccini; Marvin A Konstam; Aldo P Maggioni; Brian Traver; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; Christopher M O'Connor; Alan B Miller; Liliana Grinfeld; Mihai Gheorghiade
Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction.
American journal of therapeutics 2010;17(4):e78-87.
2010: Faisal Shamshad; Satish Kenchaiah; Peter V Finn; Jordi Soler-Soler; John J V McMurray; Eric J Velazquez; Aldo P Maggioni; Robert M Califf; Karl Swedberg; Lars Kober; Yuri Belenkov; Sergei Varshavsky; Marc A Pfeffer; Scott D Solomon
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
American heart journal 2010;160(1):145-51.
2010: Elmir Omerovic; Finn Waagstein; Karl Swedberg
Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
European journal of heart failure 2010;12(4):313-4.
2010: Periaswamy Velavan; Nasrin K Khan; Kevin Goode; Alan S Rigby; Poay H Loh; Michel Komajda; Ferenc Follath; Karl Swedberg; Hugo Madeira; John G F Cleland
Predictors of short term mortality in heart failure - insights from the Euro Heart Failure survey.
International journal of cardiology 2010;138(1):63-9.
2010: Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Luigi Tavazzi
Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).
European journal of heart failure 2010;12(1):75-81.
2009: Bradi B Granger; Inger Ekman; Christopher B Granger; Jan Ostergren; Bertil Olofsson; Eric Michelson; John J V McMurray; Salim Yusuf; Marc A Pfeffer; Karl Swedberg
Adherence to medication according to sex and age in the CHARM programme.
European journal of heart failure 2009;11(11):1092-8.
2009: Karl Swedberg
Fallacies in clinical cardiovascular trials.
Heart (British Cardiac Society) 2009;95(17):1464-8.
2009: Peter S Pang; Marvin A Konstam; Holly B Krasa; Karl Swedberg; Faiez Zannad; John E A Blair; Christopher Zimmer; John R Teerlink; Aldo P Maggioni; John C Burnett; Liliana Grinfeld; John Ouyang; James E Udelson; Mihai Gheorghiade
Effects of tolvaptan on dyspnoea relief from the EVEREST trials.
European heart journal 2009;30(18):2233-40.
2009: Colette E Jackson; Scott D Solomon; Hertzel C Gerstein; Sofia Zetterstrand; Bertil Olofsson; Eric L Michelson; Christopher B Granger; Karl Swedberg; Marc A Pfeffer; Salim Yusuf; John J V McMurray
Albuminuria in chronic heart failure: prevalence and prognostic importance.
Lancet 2009;374(9689):543-50.
2009: John J V McMurray; Inder S Anand; Rafael Diaz; Aldo P Maggioni; Christopher O'Connor; Marc A Pfeffer; Krishna R Polu; Scott D Solomon; Yan Sun; Karl Swedberg; Michal Tendera; Dirk J van Veldhuisen; Scott M Wasserman; James B Young
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
European journal of heart failure 2009;11(8):795-801.
2009: Bradi B Granger; Margarete Sandelowski; Hera Tahshjain; Karl Swedberg; Inger Ekman
A qualitative descriptive study of the work of adherence to a chronic heart failure regimen: patient and physician perspectives.
The Journal of cardiovascular nursing 2009;24(4):308-15.
2009: John E A Blair; Sadiya Khan; Marvin A Konstam; Karl Swedberg; Faiez Zannad; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; James E Udelson; Christopher A Zimmer; John Ouyang; Chien-Feng Chen; Mihai Gheorghiade
Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.
European heart journal 2009;30(13):1666-73.
2009: Kristin Falk; Harshida Patel; Karl Swedberg; Inger Ekman
Fatigue in patients with chronic heart failure - a burden associated with emotional and symptom distress.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2009;8(2):91-6.
2009: Annika Rosengren; Paul J Hauptman; Georg Lappas; Lars Olsson; Lars Wilhelmsen; Karl Swedberg
Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.
European heart journal 2009;30(9):1113-20.
2009: David Preiss; Sofia Zetterstrand; John J V McMurray; Jan Ostergren; Eric L Michelson; Christopher B Granger; Salim Yusuf; Karl Swedberg; Marc A Pfeffer; Hertzel C Gerstein; Naveed Sattar
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.
Diabetes care 2009;32(5):915-20.
2009: Masoud Shafazand; Maria Schaufelberger; Georgios Lappas; Karl Swedberg; Annika Rosengren
Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry.
European heart journal 2009;30(6):671-8.
2009: Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Craig J Reist; Paul W Armstrong; Kenneth Dickstein; Todd J Lorenz; W Brian Gibler; Vic Hasselblad; Michel Komajda; Barrie Massie; John J V McMurray; Markku Nieminen; Jean L Rouleau; Karl Swedberg; Robert M Califf
Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
American heart journal 2009;157(2):271-7.
2009: Putte Abrahamsson; Joanna Dobson; Christopher B Granger; John J V McMurray; Eric L Michelson; Marc Pfeffer; Stuart Pocock; Scott D Solomon; Salim Yusuf; Karl Swedberg
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure.
European heart journal 2009;30(3):338-45.
2009: Karl Swedberg
What should we do about heart failure: challenges for 2009.
European journal of heart failure 2009;11(1):1-2.
2008: Peter A Meredith; Jan Ostergren; Inder Anand; Margareta Puu; Scott D Solomon; Eric L Michelson; Bertil Olofsson; Christopher B Granger; Salim Yusuf; Karl Swedberg; Marc A Pfeffer; John J V McMurray
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
Journal of the American College of Cardiology 2008;52(24):2000-7.
2008: Karl Swedberg; John G F Cleland; Martin R Cowie; Markku Nieminen; silvia priori; Luigi Tavazzi; Dirk J van Veldhuisen; Luis Alonso-Pulpon; John Camm; Kenneth Dickstein; Helmut Drexler; Gerasimos Filippatos; Cecilia Linde; José Lopez-Sendon; Massimo Santini; Faiez Zannad
Successful treatment of heart failure with devices requires collaboration.
European journal of heart failure 2008;10(12):1229-35.
2008: John E A Blair; Faiez Zannad; Marvin A Konstam; Thomas Cook; Brian Traver; John C Burnett; Liliana Grinfeld; Holly Krasa; Aldo P Maggioni; Cesare Orlandi; Karl Swedberg; James E Udelson; Christopher Zimmer; Mihai Gheorghiade
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
Journal of the American College of Cardiology 2008;52(20):1640-8.
2008: Jasmine Grewal; Robert S McKelvie; Hans Persson; Peter Tait; Jonas Carlsson; Karl Swedberg; Jan Ostergren; Eva Lonn
Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
The American journal of cardiology 2008;102(6):733-7.
2008: Hertzel C Gerstein; Karl Swedberg; Jonas Carlsson; John J V McMurray; Eric L Michelson; Bertil Olofsson; Marc A Pfeffer; Salim Yusuf
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
Archives of internal medicine 2008;168(15):1699-704.
2008: Harshida Patel; Masoud Shafazand; Inger Ekman; Sören Höjgård; Karl Swedberg; Maria Schaufelberger
Home care as an option in worsening chronic heart failure -- a pilot study to evaluate feasibility, quality adjusted life years and cost-effectiveness.
European journal of heart failure 2008;10(7):675-81.
2008: Maximo Rivero-Ayerza; Wilma J M Scholte op Reimer; Mattie Lenzen; Dominic A M J Theuns; Luc Jordaens; Michel Komajda; Ferenc Follath; Karl Swedberg; John G F Cleland
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey.
European heart journal 2008;29(13):1618-24.
2008: Norman C Wang; Aldo P Maggioni; Marvin A Konstam; Faiez Zannad; Holly B Krasa; John C Burnett; Liliana Grinfeld; Karl Swedberg; James E Udelson; Thomas Cook; Brian Traver; Christopher Zimmer; Cesare Orlandi; Mihai Gheorghiade
Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction.
JAMA : the journal of the American Medical Association 2008;299(22):2656-66.
2008: Karl Swedberg
Who is an author?
European journal of heart failure 2008;10(6):523-4.
2008: Michael R MacDonald; Mark C Petrie; Fumi Varyani; Jan Ostergren; Eric L Michelson; James B Young; Scott D Solomon; Christopher B Granger; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; John J V McMurray
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2008;29(11):1377-85.
2008: Eldrin F Lewis; Eric J Velazquez; Scott D Solomon; Anne S Hellkamp; John J V McMurray; Jasmine Mathias; Jean-Lucien Rouleau; Aldo P Maggioni; Karl Swedberg; Lars Kober; Harvey White; Anthony J Dalby; Gary S Francis; Faiez Zannad; Robert M Califf; Marc A Pfeffer
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
European heart journal 2008;29(6):748-56.
2008: Jaana Javadzadeh; Anna-Clara Collén; Karin Manhem; Karl Swedberg
[Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
Läkartidningen 2008;105(9):616-9.
2008: R A P Weir; John J V McMurray; Margareta Puu; Scott D Solomon; Bertil Olofsson; Christopher B Granger; Salim Yusuf; Eric L Michelson; Karl Swedberg; Marc A Pfeffer
Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
European journal of heart failure 2008;10(2):157-63.
2007: Karl Swedberg
[Preliminary version of the National Board of Health and Welfare's new guidelines for cardiac health care. Reliable knowledge material gives basis for better care].
Läkartidningen 2007;104(46):3442-3.
2007: Akshay S Desai; Karl Swedberg; john mcmurray; Christopher B Granger; Salim Yusuf; James B Young; Mark E Dunlap; Scott D Solomon; James W Hainer; Bertil Olofsson; Eric L Michelson; Marc A Pfeffer
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
Journal of the American College of Cardiology 2007;50(20):1959-66.
2007: Mitja Lainscak; John G F Cleland; Mattie Lenzen; Samantha Nabb; Irena Keber; Ferenc Follath; Michel Komajda; Karl Swedberg
Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysis.
European journal of heart failure 2007;9(11):1095-103.
2007: Willem J Remme; John G F Cleland; Leif Erhardt; Phillip Spark; Christian Torp-Pedersen; Marco Metra; Michel Komajda; Christine Moullet; Mary Ann Lukas; Philip A Poole-Wilson; Andrea Di Lenarda; Karl Swedberg
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
European journal of heart failure 2007;9(11):1128-35.
2007: Kristin Falk; Bradi B Granger; Karl Swedberg; Inger Ekman
Breaking the vicious circle of fatigue in patients with chronic heart failure.
Qualitative health research 2007;17(8):1020-7.
2007: Inger Ekman; Maria Schaufelberger; Karin Kjellgren; Karl Swedberg; Bradi B Granger
Standard medication information is not enough: poor concordance of patient and nurse perceptions.
Journal of advanced nursing 2007;60(2):181-6.
2007: Scott D Solomon; Joanna Dobson; Stuart Pocock; Hicham Skali; john mcmurray; Christopher B Granger; Salim Yusuf; Karl Swedberg; James B Young; Eric L Michelson; Marc A Pfeffer
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.
Circulation 2007;116(13):1482-7.
2007: Marco Metra; Christian Torp-Pedersen; John G F Cleland; Andrea Di Lenarda; Michel Komajda; Willem J Remme; Livio Dei Cas; Phillip Spark; Karl Swedberg; Philip A Poole-Wilson
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET.
European journal of heart failure 2007;9(9):901-9.
2007: Satish Kenchaiah; Stuart J Pocock; Duolao Wang; Peter V Finn; Leonardo A M Zornoff; Hicham Skali; Marc A Pfeffer; Salim Yusuf; Karl Swedberg; Eric L Michelson; Christopher B Granger; john mcmurray; Scott D Solomon
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2007;116(6):627-36.
2007: Lars G Olsson; Karl Swedberg; John G F Cleland; Phillip Spark; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Willem J Remme; Armin Scherhag; Philip A Poole-Wilson
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.
European journal of heart failure 2007;9(8):795-801.
2007: Christian Torp-Pedersen; Marco Metra; Andrew Charlesworth; Phillip Spark; Mary Ann Lukas; Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Willem J Remme; Armin Scherhag
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Heart (British Cardiac Society) 2007;93(8):968-73.
2007: G Michael Felker; Larry A Allen; Stuart J Pocock; Linda K Shaw; john mcmurray; Marc A Pfeffer; Karl Swedberg; Duolao Wang; Salim Yusuf; Eric L Michelson; Christopher B Granger
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.
Journal of the American College of Cardiology 2007;50(1):40-7.
2007: Eileen O'Meara; Tim Clayton; Margaret B McEntegart; john mcmurray; Ileana L Piña; Christopher B Granger; Jan Ostergren; Eric L Michelson; Scott D Solomon; Stuart Pocock; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2007;115(24):3111-20.
2007: Christian Torp-Pedersen; Marco Metra; Phillip Spark; Mary Ann Lukas; Christine Moullet; Armin Scherhag; Michel Komajda; John G F Cleland; Willem J Remme; Andrea Di Lenarda; Karl Swedberg; Philip A Poole-Wilson
The safety of amiodarone in patients with heart failure.
Journal of cardiac failure 2007;13(5):340-5.
2007: Charles H Hennekens; Marc A Pfeffer; Karl Swedberg
The CHARM program: study design leads to findings of clinical and public health importance.
Journal of cardiovascular pharmacology and therapeutics 2007;12(2):124-6.
2007: Kristin Falk; Karl Swedberg; Fannie Gaston-Johansson; Inger Ekman
Fatigue is a prevalent and severe symptom associated with uncertainty and sense of coherence in patients with chronic heart failure.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2007;6(2):99-104.
2007: Nasrin K Khan; Kevin Goode; John G F Cleland; Alan S Rigby; Nick Freemantle; Joanne Eastaugh; Andrew L Clark; Ramesh de Silva; Melanie J Calvert; Karl Swedberg; Michael Komajda; Viu Mareev; Ferenc Follath
Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge.
European journal of heart failure 2007;9(5):491-501.
2007: Mihai Gheorghiade; Marvin A Konstam; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
JAMA : the journal of the American Medical Association 2007;297(12):1332-43.
2007: Marvin A Konstam; Mihai Gheorghiade; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
JAMA : the journal of the American Medical Association 2007;297(12):1319-31.
2007: Mitja Lainscak; John G F Cleland; Mattie Lenzen; Irena Keber; Kevin Goode; Ferenc Follath; Michel Komajda; Karl Swedberg
Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey.
The American journal of cardiology 2007;99(6B):31D-37D.
2007: Willem J Remme; Christian Torp-Pedersen; John G F Cleland; Philip A Poole-Wilson; Marco Metra; Michel Komajda; Karl Swedberg; Andrea Di Lenarda; Phillip Spark; Armin Scherhag; Christine Moullet; Mary Ann Lukas
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
Journal of the American College of Cardiology 2007;49(9):963-71.
2007: Mitja Lainscak; John G F Cleland; Mattie Lenzen; Ferenc Follath; Michel Komajda; Karl Swedberg
International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey.
European journal of heart failure 2007;9(3):292-9.
2007: Eldrin F Lewis; Gervasio A Lamas; Eileen O'Meara; Christopher B Granger; Mark E Dunlap; Robert S McKelvie; Jeffrey L Probstfield; James B Young; Eric L Michelson; Katarina Halling; Jonas Carlsson; Bertil Olofsson; john mcmurray; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
European journal of heart failure 2007;9(1):83-91.
2006: Karl Swedberg
Diagnostic and therapeutic algorithms in chronic heart failure.
Herz 2006;31(9):877-90.
2006: Kristin Falk; Karl Swedberg; Fannie Gaston-Johansson; Inger Ekman
Fatigue and anaemia in patients with chronic heart failure.
European journal of heart failure 2006;8(7):744-9.
2006: Lars Køber; Karl Swedberg; john mcmurray; Marc A Pfeffer; Eric J Velazquez; Rafael Diaz; Aldo P Maggioni; Viatcheslav Mareev; Grzegorz Opolski; Frans Van de Werf; Faiez Zannad; Georg Ertl; Scott D Solomon; Steven Zelenkofske; Jean-Lucien Rouleau; Jeffrey D Leimberger; Robert M Califf
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
European journal of heart failure 2006;8(6):591-8.
2006: john mcmurray; Karl Swedberg
Treatment of chronic heart failure: a comparison between the major guidelines.
European heart journal 2006;27(15):1773-7.
2006: Anique Ducharme; Karl Swedberg; Marc A Pfeffer; Alain Cohen-Solal; Christopher B Granger; Aldo P Maggioni; Eric L Michelson; john mcmurray; Lars Olsson; Jean L Rouleau; James B Young; Bertil Olofsson; Margareta Puu; Salim Yusuf
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
American heart journal 2006;152(1):86-92.
2006: Michel Komajda; Stefan D Anker; Andrew Charlesworth; Darlington O Okonko; Marco Metra; Andrea Di Lenarda; Willem J Remme; Christine Moullet; Karl Swedberg; John G F Cleland; Philip A Poole-Wilson
The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
European heart journal 2006;27(12):1440-6.
2006: Inger Ekman; Gull Andersson; Kurt Boman; Andrew Charlesworth; John G F Cleland; Philip A Poole-Wilson; Karl Swedberg
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial.
Patient education and counseling 2006;61(3):348-53.
2006: Lars G Olsson; Karl Swedberg; Anique Ducharme; Christopher B Granger; Eric L Michelson; john mcmurray; Margareta Puu; Salim Yusuf; Marc A Pfeffer
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Journal of the American College of Cardiology 2006;47(10):1997-2004.
2006: john mcmurray; James B Young; Mark E Dunlap; Christopher B Granger; James Hainer; Eric L Michelson; Steven Earle; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
American heart journal 2006;151(5):985-91.
2006: Anique Ducharme; Karl Swedberg; Marc A Pfeffer; Alain Cohen-Solal; Christopher B Granger; Aldo P Maggioni; Eric L Michelson; john mcmurray; Lars Olsson; Jean L Rouleau; James B Young; Salim Yusuf
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.
American heart journal 2006;151(5):985-91.
2006: John G F Cleland; Andrew Charlesworth; Jacobus Lubsen; Karl Swedberg; Willem J Remme; Leif Erhardt; Andrea Di Lenarda; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Philip A Poole-Wilson
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
Journal of the American College of Cardiology 2006;47(8):1603-11.
2006: john mcmurray; Scott Solomon; Karen Pieper; Shelby Reed; Jean Rouleau; Eric J Velazquez; Harvey White; Jonathan G Howlett; Karl Swedberg; Aldo Maggioni; Lars Køber; Frans Van de Werf; Robert M Califf; Marc Pfeffer
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Journal of the American College of Cardiology 2006;47(4):726-33.
2006: Eileen O'Meara; Tim Clayton; Margaret B McEntegart; john mcmurray; Chim C Lang; Simon D Roger; James B Young; Scott D Solomon; Christopher B Granger; Jan Ostergren; Bertil Olofsson; Eric L Michelson; Stuart Pocock; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
Circulation 2006;113(7):986-94.
2006: Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; john mcmurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick De Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Circulation 2006;113(5):671-8.
2006: Periaswamy Velavan; Nasrin K Khan; Alan S Rigby; Kevin Goode; Michel Komajda; Ferenc Follath; Karl Swedberg; HC Madeira; Andrew L Clark; John G F Cleland
Relation between severity of left ventricular systolic dysfunction and repolarisation abnormalities on the surface ECG: a report from the Euro heart failure survey.
Heart (British Cardiac Society) 2006;92(2):255-6.
2005: Scott D Solomon; Nagesh S Anavekar; Hicham Skali; john mcmurray; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Duolao Wang; Stuart Pocock; Marc A Pfeffer
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
Circulation 2005;112(24):3738-44.
2005: Bradi B Granger; Karl Swedberg; Inger Ekman; Christopher B Granger; Bertil Olofsson; john mcmurray; Salim Yusuf; Eric L Michelson; Marc A Pfeffer
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.
Lancet 2005;366(9502):2005-11.
2005: Mattie Lenzen; Eric Boersma; Wilma J M Scholte Op Reimer; Aggie H M M Balk; Michel Komajda; Karl Swedberg; Ferenc Follath; Manuel Jimenez-Navarro; Maarten L Simoons; John G F Cleland
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
European heart journal 2005;26(24):2706-13.
2005: Karl Swedberg; John G F Cleland; Henry J Dargie; Helmut Drexler; Ferenc Follath; Michel Komajda; Luigi Tavazzi; Otto A Smiseth
[Diagnosis and treatment of chronic heart disease. Guidelines of the European Society of Cardiology. Revision 2005].
Kardiologia polska 2005;63(5):509-43; discussion 544-8.
2005: Marco Metra; Christian Torp-Pedersen; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Michel Komajda; Willem J Remme; Beatrix Lutiger; Armin Scherhag; Mary Ann Lukas; Andrew Charlesworth; Philip A Poole-Wilson
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
European heart journal 2005;26(21):2259-68.
2005: Catherine Demers; john mcmurray; Karl Swedberg; Marc A Pfeffer; Christopher B Granger; Bertil Olofsson; Robert S McKelvie; Jan Ostergren; Eric L Michelson; Peter A Johansson; Duolao Wang; Salim Yusuf
Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
JAMA : the journal of the American Medical Association 2005;294(14):1794-8.
2005: Karl Swedberg; John G F Cleland; Henry J Dargie; Helmut Drexler; Ferenc Follath; Michel Komajda; Luigi Tavazzi; Otto A Smiseth; Antonello Gavazzi; Axel Haverich; Arno Hoes; Tiny Jaarsma; Jerzy Korewicki; Samuel Lévy; Cecilia Linde; José López-Sendón; Markku S Nieminen; Luc Piérard; Willem J Remme
[Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)].
Revista española de cardiología 2005;58(9):1062-92.
2005: Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos Filippatos; Guillaume Jondeau; Yonathan Hasin; Jose Lopez-Sendom; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg
[Diagnosis and treatment of acute heart failure. Guidelines of the European Society of Cardiology].
Kardiologia polska 2005;63(2):143-86; discussion 187-9.
2005: john mcmurray; Alain Cohen-Solal; Rainer Dietz; Eric Eichhorn; Leif Erhardt; F D Richard Hobbs; Henry Krum; Aldo Maggioni; Robert S McKelvie; Ileana L Piña; Jordi Soler-Soler; Karl Swedberg
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
European journal of heart failure 2005;7(5):710-21.
2005: Salim Yusuf; Jan Ostergren; Hertzel C Gerstein; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Bertil Olofsson; Jeffrey L Probstfield; John V McMurray
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure.
Circulation 2005;112(1):48-53.
2005: Karl Swedberg; Lars G Olsson; Andrew Charlesworth; John G F Cleland; Peter Hanrath; Michel Komajda; Marco Metra; Christian Torp-Pedersen; Philip A Poole-Wilson
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
European heart journal 2005;26(13):1303-8.
2005: Eileen O'Meara; Eldrin Lewis; Chris Granger; Mark E Dunlap; Robert S McKelvie; Jeffrey L Probstfield; James B Young; Eric L Michelson; Jan Ostergren; Jonas Carlsson; Bertil Olofsson; john mcmurray; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
European journal of heart failure 2005;7(4):650-6.
2005: Andrea Di Lenarda; Willem J Remme; Andrew Charlesworth; John G F Cleland; Beatrix Lutiger; Marco Metra; Michel Komajda; Christian Torp-Pedersen; Armin Scherhag; Karl Swedberg; Philip A Poole-Wilson
Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
European journal of heart failure 2005;7(4):640-9.
2005: Inger Ekman; Kurt Boman; Mona Olofsson; Nibia Aires; Karl Swedberg
Gender makes a difference in the description of dyspnoea in patients with chronic heart failure.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2005;4(2):117-21.
2005: Karl Swedberg; John G F Cleland; Henry J Dargie; Helmut Drexler; Ferenc Follath; Michel Komajda; Luigi Tavazzi; Otto A Smiseth; Antonello Gavazzi; Axel Haverich; Arno Hoes; Tiny Jaarsma; Jerzy Korewicki; Samuel Lévy; Cecilia Linde; Jose Lopez-Sendon; Markku S Nieminen; Luc Piérard; Willem J Remme
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.
European heart journal 2005;26(11):1115-40.
2005: Inger Ekman; John G F Cleland; Karl Swedberg; Andrew Charlesworth; Marco Metra; Philip A Poole-Wilson
Symptoms in patients with heart failure are prognostic predictors: insights from COMET.
Journal of cardiac failure 2005;11(4):288-92.
2005: Mihai Gheorghiade; Cesare Orlandi; John C Burnett; David L DeMets; Liliana Grinfeld; Aldo Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Christopher Zimmer; Marvin A Konstam
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).
Journal of cardiac failure 2005;11(4):260-9.
2005: Karl Swedberg
What can we learn from Europe?
Heart (British Cardiac Society) 2005;91 Suppl 2():ii21-3; discussion ii31, ii43-8.
2005: Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos Filippatos; Guillaume Jondeau; Yonathan Hasin; Jose Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg
[Executive summary of the guidelines on the diagnosis and treatment of acute heart failure].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 2005;6(4):218-54.
2005: Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos Filippatos; Guillaume Jondeau; Yonathan Hasin; José López-Sendón; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg
[Executive summary of the guidelines on the diagnosis and treatment of acute heart failure].
Revista española de cardiología 2005;58(4):389-429.
2005: Lars G Olsson; Karl Swedberg; Andrew L Clark; Klaus K Witte; John G F Cleland
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review.
European heart journal 2005;26(8):778-93.
2005: Christian Torp-Pedersen; Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Beatrix Lutiger; Marco Metra; Willem J Remme; Armin Scherhag; Allan Skene
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
American heart journal 2005;149(2):370-6.
2005: Mika Lehto; Steven M Snapinn; Kenneth Dickstein; Karl Swedberg; Markku S Nieminen
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.
European heart journal 2005;26(4):350-6.
2005: Karl Swedberg
Should elderly heart failure patients be treated with beta-blockade therapy?
Nature clinical practice. Cardiovascular medicine 2005;2(1):14-5.
2005: Eric Stanton; Mark S Hansen; Michael J Sole; Yehia Gawad; Milton Packer; Bertram Pitt; Karl Swedberg; Jean-Lucien Rouleau
Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.
The Canadian journal of cardiology 2005;21(1):39-43.
2004: john mcmurray; Marc A Pfeffer; Karl Swedberg; Victor J Dzau
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
Circulation 2004;110(20):3281-8.
2004: Eileen O'Meara; Scott Solomon; john mcmurray; Marc Pfeffer; Salim Yusuf; Eric L Michelson; Chris Granger; Bertil Olofsson; James B Young; Karl Swedberg
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2004;25(21):1920-6.
2004: James B Young; Mark E Dunlap; Marc A Pfeffer; Jeffrey L Probstfield; Alain Cohen-Solal; Rainer Dietz; Christopher B Granger; Jaromir Hradec; Jerzy Kuch; Robert S McKelvie; john mcmurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Peter Held; Scott D Solomon; Salim Yusuf; Karl Swedberg
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
Circulation 2004;110(17):2618-26.
2004: Scott D Solomon; Duolao Wang; Peter Finn; Hicham Skali; Leonardo A M Zornoff; john mcmurray; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Stuart Pocock; Marc A Pfeffer
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2004;110(15):2180-3.
2004: Karl Swedberg
Conclusions on the management of heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5 Suppl 1():S34-6.
2004: Maria Schaufelberger; Claes-Håkan Bergh; Kenneth Caidahl; Robert Eggertsen; Eva Furenäs; Göran Lindstedt; Thomas Nilsson; Kari Stefferud; Karl Swedberg
Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?
Scandinavian journal of primary health care 2004;22(3):187-90.
2004: Mattie Lenzen; Wilma J M Scholte op Reimer; Eric Boersma; P J M J Vantrimpont; Ferenc Follath; Karl Swedberg; J Cleland; Michel Komajda
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.
European heart journal 2004;25(14):1214-20.
2004: John G F Cleland; Kevin Goode; Leif Erhardt; Willem J Remme; Andrew Charlesworth; Philip A Poole-Wilson; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Marco Metra; Karl Swedberg; Christian Torp-Pedersen
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET).
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(2):139-52.
2004: Karen Hogg; Karl Swedberg; john mcmurray
Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.
Journal of the American College of Cardiology 2004;43(3):317-27.
2004: Maria Schaufelberger; Karl Swedberg; Max Köster; Måns Rosén; Annika Rosengren
Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.
European heart journal 2004;25(4):300-7.
2003: Marc A Pfeffer; john mcmurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
The New England journal of medicine 2003;349(20):1893-906.
2003: Jay N Cohn; Marc A Pfeffer; Jean Rouleau; Norman Sharpe; Karl Swedberg; Matthias Straub; Curtis G Wiltse; Theressa J Wright
Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).
European journal of heart failure 2003;5(5):659-67.
2003: Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; john mcmurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
Lancet 2003;362(9386):777-81.
2003: Christopher B Granger; john mcmurray; Salim Yusuf; Peter Held; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Marc A Pfeffer; Karl Swedberg
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Lancet 2003;362(9386):772-6.
2003: john mcmurray; Jan Ostergren; Karl Swedberg; Christopher B Granger; Peter Held; Eric L Michelson; Bertil Olofsson; Salim Yusuf; Marc A Pfeffer
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
Lancet 2003;362(9386):767-71.
2003: Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; john mcmurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Stuart Pocock
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Lancet 2003;362(9386):759-66.
2003: Eric J Velazquez; Marc A Pfeffer; John V McMurray; Aldo P Maggioni; Jean-Lucien Rouleau; Frans Van de Werf; Lars Kober; Harvey D White; Karl Swedberg; Jeffrey D Leimberger; Paul Gallo; Mary Ann Sellers; Susan Edwards; Marc Henis; Robert M Califf
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
European journal of heart failure 2003;5(4):537-44.
2003: Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Lancet 2003;362(9377):7-13.
2003: john mcmurray; Jan Ostergren; Marc Pfeffer; Karl Swedberg; Chris Granger; Salim Yusuf; Peter Held; Eric L Michelson; Bertil Olofsson
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European journal of heart failure 2003;5(3):261-70.
2003: Jean-Lucien Rouleau; Bertram Pitt; N S Dhalla; K S Dhalla; Karl Swedberg; Mark S Hansen; Eric Stanton; N Lapointe; Milton Packer
Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failure.
American heart journal 2003;145(5):926-32.
2003: Mihai Gheorghiade; Wilson S Colucci; Karl Swedberg
Beta-blockers in chronic heart failure.
Circulation 2003;107(12):1570-5.
2003: Michel Komajda; Ferenc Follath; Karl Swedberg; John G F Cleland; J Cosin Aguilar; A Cohen-Solal; R Dietz; Antonello Gavazzi; WH van Gilst; Richard F D Hobbs; Jerzy Korewicki; HC Madeira; V S Moiseyev; István Préda; J Widimsky; Nick Freemantle; Joanne Eastaugh; J Mason
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.
European heart journal 2003;24(5):464-74.
2003: John G F Cleland; Karl Swedberg; Ferenc Follath; Michel Komajda; A Cohen-Solal; J Cosin Aguilar; R Dietz; Antonello Gavazzi; Richard F D Hobbs; Jerzy Korewicki; HC Madeira; V S Moiseyev; István Préda; WH van Gilst; J Widimsky; Nick Freemantle; Joanne Eastaugh; J Mason
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.
European heart journal 2003;24(5):442-63.
2003: Thorarinn Gudnason; Thórdís Hrafnkelsdóttir; Ulrika Wall; Karl Swedberg; Sverker Jern
Fibrinolytic capacity increases with age in healthy humans, while endothelium-dependent vasodilation is unaffected.
Thrombosis and haemostasis 2003;89(2):374-81.
2002: John G F Cleland; A Cohen-Solal; J Cosin Aguilar; R Dietz; Joanne Eastaugh; Ferenc Follath; Nick Freemantle; Antonello Gavazzi; WH van Gilst; F D Richard Hobbs; Jerzy Korewicki; HC Madeira; István Préda; Karl Swedberg; J Widimsky
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.
Lancet 2002;360(9346):1631-9.
2002: Mark S Hansen; Eric Stanton; Yehia Gawad; Milton Packer; Bertram Pitt; Karl Swedberg; Jean-Lucien Rouleau
Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan.
The American journal of cardiology 2002;90(9):969-73.
2002: Karl Swedberg
Current perspectives for AT(1)-receptor blockers in the management of heart failure.
Journal of human hypertension 2002;16 Suppl 3():S47-51.
2002: Birgitta Houltz; Börje Darpö; Harry J G M Crijns; Karl Swedberg; Per Blomström; Steen M Jensen; Elisabeth Svernhage; Nils Edvardsson
QRS aberration during atrial fibrillation at rest and during exercise. Effect of a selective potassium channel blocking agent.
Journal of electrocardiology 2002;35(3):201-12.
2002: Philip A Poole-Wilson; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Marco Metra; Willem J Remme; Karl Swedberg; Christian Torp-Pedersen
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.
European journal of heart failure 2002;4(3):321-9.
2002: Monica R Shah; Vic Hasselblad; Sandra S Stinnett; Judith M Kramer; Steven Grossman; Mihai Gheorghiade; Kirkwood F Adams; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure.
European journal of heart failure 2002;4(3):297-304.
2002: Karl Swedberg; Michael R Bristow; Jay N Cohn; Henry J Dargie; Matthias Straub; Curtis G Wiltse; Theressa J Wright
Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure.
Circulation 2002;105(15):1797-803.
2001: Monica R Shah; Vic Hasselblad; Mihai Gheorghiade; Kirkwood F Adams; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy.
The American journal of cardiology 2001;88(9):987-93.
2001: Willem J Remme; Karl Swedberg
Guidelines for the diagnosis and treatment of chronic heart failure.
European heart journal 2001;22(17):1527-60.
2001: john mcmurray; A Cohen-Solal; R Dietz; Eric Eichhorn; L Erhardt; Richard F D Hobbs; Aldo Maggioni; I Pina; Jordi Soler-Soler; Karl Swedberg
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.
European journal of heart failure 2001;3(4):495-502.
2001: Per Johanson; Karl Swedberg; Mikael Dellborg
ST variability during the first 4 hours of acute myocardial infarction predicts 1-year mortality.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2001;6(3):198-202.
2001: Monica R Shah; Vic Hasselblad; Sandra S Stinnett; Mihai Gheorghiade; Karl Swedberg; Robert M Califf; Christopher M O'Connor
Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes.
Journal of cardiac failure 2001;7(2):105-13.
2001: Maria Schaufelberger; B O Eriksson; Lars Lönn; B Rundqvist; Katharina Sunnerhagen; Karl Swedberg
Skeletal muscle characteristics, muscle strength and thigh muscle area in patients before and after cardiac transplantation.
European journal of heart failure 2001;3(1):59-67.
2000: M R Shah; Christopher B Granger; BA Bart; J J McMurray; M C Petrie; Eric L Michelson; Gail Tudor; Karl Swedberg; L W Stevenson; Robert M Califf; Marc A Pfeffer
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry.
The American journal of medicine 2000;109(6):489-92.
2000: Karl Swedberg
Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies.
European journal of heart failure 2000;2(3):229-33.
2000: John G F Cleland; Karl Swedberg; A Cohen-Solal; J Cosin-Aguilar; R Dietz; Ferenc Follath; Antonello Gavazzi; Richard F D Hobbs; Jerzy Korewicki; HC Madeira; István Préda; W H van Gilst; J Widimsky; V Mareev; J Mason; Nick Freemantle; Joanne Eastaugh
The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York.
European journal of heart failure 2000;2(2):123-32.
2000: Christopher B Granger; G Ertl; Jerzy Kuch; A P Maggioni; john mcmurray; J L Rouleau; L W Stevenson; Karl Swedberg; J Young; Salim Yusuf; Robert M Califf; BA Bart; Peter Held; Eric L Michelson; M A Sellers; G Ohlin; rodney sparapani; Marc A Pfeffer
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
American heart journal 2000;139(4):609-17.
2000: Karl Swedberg; Claes-Håkan Bergh; Kenneth Dickstein; J McNay; M Steinberg
The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Moxonidine Investigators.
Journal of the American College of Cardiology 2000;35(2):398-404.
2000: Birgitta Houltz; Börje Darpö; Karl Swedberg; Per Blomström; Harry J G M Crijns; Steen M Jensen; Elisabeth Svernhage; Nils Edvardsson
Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2000;2(1):20-31.
2000: Karl Swedberg
Exploring new treatment strategies in heart failure.
Blood pressure. Supplement 2000;1():44-8.
1999: Karl Swedberg; M Pfeffer; Chris Granger; Peter Held; john mcmurray; G Ohlin; B Olofsson; Jan Ostergren; Salim Yusuf
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.
Journal of cardiac failure 1999;5(3):276-82.
1999: BA Bart; G Ertl; P Held; Jerzy Kuch; A P Maggioni; john mcmurray; Eric L Michelson; J L Rouleau; L Warner Stevenson; Karl Swedberg; James B Young; Salim Yusuf; M A Sellers; Christopher B Granger; Robert M Califf; Marc A Pfeffer
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
European heart journal 1999;20(16):1182-90.
1999: Birgitta Houltz; Börje Darpö; Karl Swedberg; Per Blomström; J Brachmann; Harry J G M Crijns; Steen M Jensen; Elisabeth Svernhage; H Vallin; Nils Edvardsson
Effects of the Ikr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1999;13(4):329-38.
1999: Christopher M O'Connor; Wendy A Gattis; Karl Swedberg
Current and novel pharmacologic approaches in advanced heart failure.
Heart & lung : the journal of critical care 1999;28(4):227-42.
1999: Christopher M O'Connor; Wendy A Gattis; B F Uretsky; Kirkwood F Adams; SE McNulty; S H Grossman; WJ McKenna; F Zannad; Karl Swedberg; Mihai Gheorghiade; Robert M Califf
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
American heart journal 1999;138(1 Pt 1):78-86.
1999: Karl Swedberg
Beta-blockers and heart failure.
Journal of cardiovascular risk 1999;6(3):129-30.
1999: Christopher M O'Connor; Wendy A Gattis; F Zannad; SE McNulty; Mihai Gheorghiade; Kirkwood F Adams; Robert M Califf; WJ McKenna; J Soler-Soler; Karl Swedberg
Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes.
European journal of heart failure 1999;1(1):81-8.
1999: Karl Swedberg; John Kjekshus; S Snapinn
Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I.
European heart journal 1999;20(2):136-9.
1998: Maria Schaufelberger; H Drexler; E Schieffer; Karl Swedberg
Angiotensin-converting enzyme gene expression in skeletal muscle in patients with chronic heart failure.
Journal of cardiac failure 1998;4(3):185-91.
1998: Karl Swedberg
Impact of neuroendocrine activation on coronary artery disease.
The American journal of cardiology 1998;82(3A):8H-14H.
1998: John G F Cleland; Karl Swedberg; P A Poole-Wilson
Successes and failures of current treatment of heart failure.
Lancet 1998;352 Suppl 1():SI19-28.
1998: Christopher M O'Connor; Wendy A Gattis; Karl Swedberg
Current and novel pharmacologic approaches in advanced heart failure.
American heart journal 1998;135(6 Pt 2 Su):S249-63.
1998: Birgitta Houltz; Börje Darpö; Nils Edvardsson; Per Blomström; J Brachmann; Harry J G M Crijns; Steen M Jensen; Elisabeth Svernhage; H Vallin; Karl Swedberg
Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.
Pacing and clinical electrophysiology : PACE 1998;21(5):1044-57.
1997: Johan Herlitz; Finn Waagstein; Jonny Lindqvist; Karl Swedberg; Ake Hjalmarson
Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg Metoprolol Trial).
The American journal of cardiology 1997;80(9B):40J-44J.
1997: P Eriksson; K Andersen; Karl Swedberg; Mikael Dellborg
Vectorcardiographic monitoring of patients with acute myocardial infarction and chronic bundle branch block.
European heart journal 1997;18(8):1288-95.
1997: Robert M Califf; Kirkwood F Adams; WJ McKenna; Mihai Gheorghiade; B F Uretsky; SE McNulty; Harald Darius; Kevin Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; Karl Swedberg
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).
American heart journal 1997;134(1):44-54.
1997: Maria Schaufelberger; B O Eriksson; G Grimby; P Held; Karl Swedberg
Skeletal muscle alterations in patients with chronic heart failure.
European heart journal 1997;18(6):971-80.
1996: Karl Swedberg; A Sigurdsson
The use of ACE inhibitors after myocardial infarction.
Journal of cardiac failure 1996;2(4 Suppl):S231-7.
1996: M Schaufelberger; G Andersson; B O Eriksson; G Grimby; P Held; Karl Swedberg
Skeletal muscle changes in patients with chronic heart failure before and after treatment with enalapril.
European heart journal 1996;17(11):1678-85.
1996: K Andersen; Mikael Dellborg; H Emanuelsson; L Grip; Karl Swedberg
Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment.
Coronary artery disease 1996;7(9):673-81.
1996: Karl Swedberg; N Sharpe
The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarction.
European heart journal 1996;17(9):1306-11.
1996: I Wiklund; F Waagstein; Karl Swedberg; A Hjalmarsson
Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1996;10(3):361-8.
1996: M Schaufelberger; B O Eriksson; P Held; Karl Swedberg
Skeletal muscle metabolism during exercise in patients with chronic heart failure.
Heart (British Cardiac Society) 1996;76(1):29-34.
1996: A Sigurdsson; Karl Swedberg
The role of neurohormonal activation in chronic heart failure and postmyocardial infarction.
American heart journal 1996;132(1 Pt 2 Su):229-34.
1996: Karl Swedberg
What have we learned from clinical trials in congestive heart failure?
Journal of internal medicine 1996;239(4):307-8.
1996: K Andersen; M Dellborg; Karl Swedberg
Nucleoside transport inhibition by draflazine in unstable coronary disease.
European journal of clinical pharmacology 1996;51(1):7-13.
1995: A Sigurdsson; Karl Swedberg
Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
European heart journal 1995;16 Suppl N():65-72.
1995: M Dellborg; Klas Malmberg; L Rydén; A M Svensson; Karl Swedberg
Dynamic on-line vectorcardiography improves and simplifies in-hospital ischemia monitoring of patients with unstable angina.
Journal of the American College of Cardiology 1995;26(6):1501-7.
1995: A Sigurdsson; Karl Swedberg
Prevention of congestive heart failure by ACE inhibition in patients with acute myocardial infarction.
Journal of cardiovascular risk 1995;2(5):406-12.
1995: M Schaufelberger; B O Eriksson; G Grimby; P Held; Karl Swedberg
Skeletal muscle fiber composition and capillarization in patients with chronic heart failure: relation to exercise capacity and central hemodynamics.
Journal of cardiac failure 1995;1(4):267-72.
1995: A Sigurdsson; Karl Swedberg
ACE inhibitors in patients with minimal or asymptomatic left ventricular dysfunction.
Coronary artery disease 1995;6(4):288-94.
1994: A Sigurdsson; Karl Swedberg
Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?
British heart journal 1994;72(3 Suppl):S75-80.
1994: A Sigurdsson; Karl Swedberg
Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction.
European heart journal 1994;15 Suppl B():14-9; discussion 26-30.
1994: M Dellborg; P Eriksson; M Riha; Karl Swedberg
Declining hospital mortality in acute myocardial infarction.
European heart journal 1994;15(1):5-9.
1994: M Dellborg; J Herlitz; H Emanuelsson; Karl Swedberg
ECG changes during myocardial ischemia. Differences between men and women.
Journal of electrocardiology 1994;27 Suppl():42-5.
1994: Karl Swedberg
Exercise testing in heart failure. A critical review.
Drugs 1994;47 Suppl 4():14-24.
1993: Nils Edvardsson; Birgitta Houltz; Karl Swedberg
[Torsades de pointes--a rare (?) and unpredictable arrhythmia].
Läkartidningen 1993;90(50):4540.
1993: F Waagstein; M R Bristow; Karl Swedberg; F Camerini; M B Fowler; M A Silver; E M Gilbert; M R Johnson; F G Goss; A Hjalmarson
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
Lancet 1993;342(8885):1441-6.
1993: A Sigurdsson; P Held; Karl Swedberg
Short- and long-term neurohormonal activation following acute myocardial infarction.
American heart journal 1993;126(5):1068-76.
1993: M Dellborg; Karl Swedberg
Acute myocardial infarction: difference in the treatment between men and women.
Quality assurance in health care : the official journal of the International Society for Quality Assurance in Health Care / ISQA 1993;5(3):261-5.
1993: A Sigurdsson; P Held; Karl Swedberg; B Wall
Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling.
European heart journal 1993;14(8):1110-7.
1993: M Dellborg; Johan Herlitz; M Risenfors; Karl Swedberg
Electrocardiographic assessment of infarct size: comparison between QRS scoring of 12-lead electrocardiography and dynamic vectorcardiography.
International journal of cardiology 1993;40(2):167-72.
1993: Karl Swedberg
Reduction in mortality by pharmacological therapy in congestive heart failure.
Circulation 1993;87(5 Suppl):IV126-9.
1993: Karl Swedberg
Initial experience with beta blockers in dilated cardiomyopathy.
The American journal of cardiology 1993;71(9):30C-38C.
1993: M Dellborg; A M Svensson; M Johansson; Karl Swedberg
Early electrocardiographic changes in acute myocardial infarction treated by streptokinase or alteplase: a randomized study with dynamic, multi-lead, electrocardiographic monitoring.
Cardiology 1993;82(6):368-76.
1993: M Dellborg; H Emanuelsson; Karl Swedberg
Silent myocardial ischemia during coronary angioplasty.
Cardiology 1993;82(5):325-34.
1993: M Dellborg; P G Steg; M Simoons; R Dietz; S Sen; M van den Brand; U Lotze; S Hauck; J M Juliard; Karl Swedberg
Increased rate of evolution of QRS changes in patients with acute myocardial infarction. Results from the Vermut Study.
Journal of electrocardiology 1993;26 Suppl():244-8.
1992: Karl Swedberg; P Held; J Kjekshus; K Rasmussen; L Rydén; H Wedel
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
The New England journal of medicine 1992;327(10):678-84.
1992: M Dellborg; G Gustafsson; M Riha; Karl Swedberg
Dynamic changes of the QRS complex in unstable angina pectoris.
International journal of cardiology 1992;36(2):151-62.
1992: J Markenvard; M Dellborg; R Jagenburg; Karl Swedberg
The predictive value of CKMB mass concentration in unstable angina pectoris: preliminary report.
Journal of internal medicine 1992;231(4):433-6.
1991: M Dellborg; Eric J Topol; Karl Swedberg
Dynamic QRS complex and ST segment vectorcardiographic monitoring can identify vessel patency in patients with acute myocardial infarction treated with reperfusion therapy.
American heart journal 1991;122(4 Pt 1):943-8.
1991: A Sigurdsson; P Held; G Andersson; Karl Swedberg
Enalaprilat in acute myocardial infarction: tolerability and effects on the renin-angiotensin system.
International journal of cardiology 1991;33(1):115-24.
1991: B Hornestam; M Dellborg; Karl Swedberg; J Wallin; M Riha
[Heart-lung radiography after myocardial infarction is of insignificant value for the estimation of prognosis].
Läkartidningen 1991;88(26-27):2390-2.
1991: M Dellborg; M Riha; Karl Swedberg
Dynamic QRS-complex and ST-segment monitoring in acute myocardial infarction during recombinant tissue-type plasminogen activator therapy. The TEAHAT Study Group.
The American journal of cardiology 1991;67(5):343-9.
1991: Karl Swedberg
Effect of ACE-inhibition on renal function in severe congestive heart failure.
Zeitschrift für Kardiologie 1991;80 Suppl 2():50-4.
1991: Johan Herlitz; M Dellborg; Marianne Hartford; T Karlsson; M Risenfors; B W Karlson; Russell V Luepker; Stig Holmberg; Karl Swedberg; A Hjalmarsson
Mortality and morbidity 1 year after early thrombolysis in suspected AMI: results from the TEAHAT Study.
Journal of internal medicine. Supplement 1991;734():43-51.
1991: M Risenfors; Johan Herlitz; C H Berg; M Dellborg; G Gustavsson; C Gottfridsson; M Lomsky; Karl Swedberg; A Hjalmarsson
Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: results from the TEAHAT Study.
Journal of internal medicine. Supplement 1991;734():35-42.
1991: M Risenfors; G Gustavsson; Lars Ekström; Marianne Hartford; Johan Herlitz; B W Karlson; Russell V Luepker; Karl Swedberg; Bertil Wennerblom; Stig Holmberg
Prehospital thrombolysis in suspected acute myocardial infarction: results from the TEAHAT Study.
Journal of internal medicine. Supplement 1991;734():3-10.
1991: M Risenfors; Marianne Hartford; M Dellborg; Russell V Luepker; A Hjalmarsson; Karl Swedberg; Stig Holmberg; Johan Herlitz
Effect of early intravenous rt-PA on infarct size estimated from serum enzyme activity: results from the TEAHAT Study.
Journal of internal medicine. Supplement 1991;734():11-8.
1991: M Dellborg; G Gustafsson; Karl Swedberg
Buccal versus intravenous nitroglycerin in unstable angina pectoris.
European journal of clinical pharmacology 1991;41(1):5-9.
1990: Karl Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
Circulation 1990;82(5):1730-6.
1990: Karl Swedberg; J Kjekshus
Effect of enalapril on mortality in congestive heart failure. Follow-up survival data from the CONSENSUS trial.
Drugs 1990;39 Suppl 4():49-52; discussion 53-4.
1990: M Dellborg; M Riha; Karl Swedberg
Dynamic QRS and ST-segment changes in myocardial infarction monitored by continuous on-line vectorcardiography.
Journal of electrocardiology 1990;23 Suppl():11-9.
1989: M Schaufelberger; G Gustafsson; P Held; Karl Swedberg
[Various methods of evaluating patients with heart failure].
Läkartidningen 1989;86(28-29):2528-30.
1988: Karl Swedberg
Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? II. Protagonist's viewpoint.
Journal of the American College of Cardiology 1988;12(2):550-4.
1988: Karl Swedberg; J Kjekshus
Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
The American journal of cardiology 1988;62(2):60A-66A.
1988: Johan Herlitz; Ake Hjalmarson; Karl Swedberg; L Rydén; F Waagstein
Effects on mortality during five years after early intervention with metoprolol in suspected acute myocardial infarction.
Acta medica Scandinavica 1988;223(3):227-31.
1988: G Stenström; Karl Swedberg
QRS amplitudes, QTc intervals and ECG abnormalities in pheochromocytoma patients before, during and after treatment.
Acta medica Scandinavica 1988;224(3):231-5.
1987: P Held; Karl Swedberg
Haemodynamic effects of felodipine in congestive heart failure.
Drugs 1987;34 Suppl 3():81-4.